A St. Louis jury has rejected a woman’s case that claimed she contracted ovarian and uterine cancer because of long-term use of Johnson & Johnson talcum powder, according to U.S. News. The jury voted 11-1 against the plaintiff, Nora Daniels, who claimed to have used the product continually for three and a half decades.
Previous St. Louis juries had awarded nearly $200 million to plaintiffs in similar suits. ...
continue reading...
Two New Jersey plaintiffs are seeking to reinstate their cases against Johnson & Johnson, claiming they developed ovarian cancer as a result of using the company’s Shower to Shower product line.
Superior Court Judge Nelson Johnson initially threw out the cases of Diana Balderrama and Brandi Carl because he rejected the expert testimony presented on their behalf. In their appeal, the plaintiffs assert Judge Johnson “misapplied ...
continue reading...
Former users of Janssen Pharmaceuticals’ antipsychotic drug Risperdal continue to feel the impact of a long-undisclosed potential side effect of the medication. The drug is intended to treat schizophrenia and bipolar disorder, however, since its release, multiple misrepresentations about Risperdal have been made to patients and their doctors. In perhaps the most glaring example, some males who have used the drug have developed a disorder called gynecomastia. The condition causes them ...
Both sides made their case and the decision was left to the jury. That jury came back with its decision and a very powerful message. $30 million was to paid by Johnson & Johnson for damages sustained by the plaintiffs after receiving Pinnacle hip replacement implants. An additional $1 billion was to be paid in punitive damages.
That verdict was just one in a series of losses for the medical ...
continue reading...The Pinnacle hip implant, last sold by Johnson & Johnson in 2013, still appears to have the full faith of the healthcare giant behind it. After going to trial and losing on multiple occasions, J&J is now questioning the fairness of the latest verdict given by a jury; a verdict that called for $1 billion in punitive damages to be levied against the ...
Ethicon’s decision to pull its Physiomesh surgical mesh off the market earlier this year is just one more in a string of failures for the medical device unit of Johnson & Johnson. The decision comes from mounting evidence of a higher number of revision surgeries associated with Physiomesh than with other similar surgical mesh devices.
Data compiled from two separate hernia registries showed ...
continue reading...
